Micotil
Banned
- Joined
- Nov 13, 2010
- Messages
- 895
- Reaction score
- 102
- Points
- 18
Pharming: Promises and risks ofbBiopharmaceuticals derived from genetically modified plants and animals (Ethics of Science and Technology Assessment)
Eckard Rehbinder (Author), Margret Engelhard (Author), Kristin Hagen (Author), R. B. Jørgensen (Author), Rafael Pardo Avellaneda (Author), Angelika Schnieke (Author), Felix Thiele (Author)
Price:$119.00
Product Details
Paperback: 354 pages
Publisher: Springer; Softcover reprint of hardcover 1st ed. 2009 edition (December 15, 2010)
Language: English
ISBN-10: 3642099351
ISBN-13: 978-3642099359
Product Dimensions: 9 x 6 x 0.8 inches
Product Description
A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics.
Eckard Rehbinder (Author), Margret Engelhard (Author), Kristin Hagen (Author), R. B. Jørgensen (Author), Rafael Pardo Avellaneda (Author), Angelika Schnieke (Author), Felix Thiele (Author)
Price:$119.00
Product Details
Paperback: 354 pages
Publisher: Springer; Softcover reprint of hardcover 1st ed. 2009 edition (December 15, 2010)
Language: English
ISBN-10: 3642099351
ISBN-13: 978-3642099359
Product Dimensions: 9 x 6 x 0.8 inches
Product Description
A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics.
Last edited: